NTC was founded in 1997 and started to be active in Europe and some selective markets in Asia. The first licensing-out agreement for a pharmaceutical product was signed by NTC with the company Hyundai Pharm. Ind. Co. Ltd. during the year 1998. The products D-SEB and PENTRAX were launched in Saudi-Arabia during 1999. In 2000 NTC started the development of several medical devices and pharmaceutical products in nebules presentation. Among those, BLUYAL was launched in Italy during the year 2000 and it is at present among the top in its therapeutical class. The first two generics of NTC were launched in 2001 in Italy through agreements with two generic multinational companies.